secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2024-12-18T23:59:59+00:00
Accession:  0001104659-24-129592
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Esperion completes $100M convertible note issuance and exchange of 2025 notes
-----------------------------------------------------------------------------

- Issued $100M aggregate principal of 5.75% Convertible Senior Subordinated Notes due June 15, 2030.
- Exchanged ~$210.1M of existing 4.00% 2025 Notes for ~$57.5M new notes plus ~$153.4M cash.
- Sold ~$42.5M of new notes for cash; net proceeds for general corporate purposes.
- Initial conversion rate 326.7974 shares per $1,000 principal, conversion price ~$3.06 per share.
- New notes are senior unsecured, redeemable after Dec 20, 2027 under certain conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465924129592/0001104659-24-129592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465924129592/tm2430949d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-129592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer